Physician profile
Thomas W Madden
NPI 1265523138
$4,291.56
in general payments reported to CMS, 2019-2025
15 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2020: $206 · 2021: $222 · 2022: $1,811 · 2023: $335 · 2024: $1,202 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,915.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,915.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,379.68 | 2022 | |
| Convatec INC. | $1,216.45 | 2023-2025 | |
| Stryker Corporation | $443.62 | 2020-2025 | Anchorage, Viaflow, Actishield |
| Kerecis Limited | $388.37 | 2020-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Pylant Medical | $242.22 | 2022-2025 | |
| Bioventus LLC | $128.07 | 2019-2024 | Exogen Ultrasound Bone Healing System |
| Treace Medical Concepts, INC. | $120.28 | 2022 | |
| Organogenesis INC. | $85.30 | 2019 | |
| Integra Lifesciences Corporation | $80.65 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $73.20 | 2020-2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Cap |
| Smith+Nephew, INC. | $48.00 | 2020 | |
| Polynovo North America LLC | $23.03 | 2025 | Novosorb Btm |
| Wright Medical Technology, INC. | $22.01 | 2020 | |
| Misonix INC | $20.90 | 2019 | |
| Anika Therapeutics, INC. | $19.78 | 2023 | Toe Motion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Madden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.